DE3867445D1 - Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren. - Google Patents

Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.

Info

Publication number
DE3867445D1
DE3867445D1 DE8888119790T DE3867445T DE3867445D1 DE 3867445 D1 DE3867445 D1 DE 3867445D1 DE 8888119790 T DE8888119790 T DE 8888119790T DE 3867445 T DE3867445 T DE 3867445T DE 3867445 D1 DE3867445 D1 DE 3867445D1
Authority
DE
Germany
Prior art keywords
trometamol
amino acids
basic amino
thioctseate
salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8888119790T
Other languages
German (de)
English (en)
Inventor
Helmut Dr Hettche
Reinhard Dr Muckenschnabel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meda Pharma GmbH and Co KG
Original Assignee
Asta Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6341895&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE3867445(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Pharma AG filed Critical Asta Pharma AG
Priority to DE8888119790T priority Critical patent/DE3867445D1/de
Application granted granted Critical
Publication of DE3867445D1 publication Critical patent/DE3867445D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE8888119790T 1987-12-04 1988-11-28 Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren. Expired - Lifetime DE3867445D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE8888119790T DE3867445D1 (de) 1987-12-04 1988-11-28 Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3741152 1987-12-04
DE8888119790T DE3867445D1 (de) 1987-12-04 1988-11-28 Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.

Publications (1)

Publication Number Publication Date
DE3867445D1 true DE3867445D1 (de) 1992-02-13

Family

ID=6341895

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888119790T Expired - Lifetime DE3867445D1 (de) 1987-12-04 1988-11-28 Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.

Country Status (7)

Country Link
EP (1) EP0318891B1 (enExample)
AT (1) ATE70974T1 (enExample)
DE (1) DE3867445D1 (enExample)
ES (1) ES2038733T3 (enExample)
GR (1) GR3003517T3 (enExample)
IE (1) IE60877B1 (enExample)
PT (1) PT89144B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
EP0812590A3 (de) * 1989-11-09 1999-06-09 ASTA Medica Aktiengesellschaft Verwendung von R-Alpha-Liponsäure zur Zytoprotektion
BE1003834A5 (fr) * 1989-11-09 1992-06-23 Asta Medica Ag Medicaments qui contiennent, comme substance active, des acides carboxyliques contenant du soufre, ainsi que leur utilisation pour lutter contre des retrovirus.
DE59209162D1 (de) * 1991-07-05 1998-03-05 Asta Medica Ag Verwendung von Schwefel enthaltenden Carbonsäuren zur Bekämpfung von pathophysiologisch bedingten Erregungsstörungen
DE9213914U1 (de) * 1992-10-15 1992-12-03 Asta Medica AG, 6000 Frankfurt Ampulle und Infusionslösung von Thioctsäure in Form der wasserlöslichen Salze der Thioctsäure
DE29506604U1 (de) * 1995-04-25 1995-06-14 Asta Medica Ag, 01277 Dresden Fertiginfusionsset
EP1023284B1 (en) * 1996-07-05 2005-11-23 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds
DE19806354B4 (de) * 1998-02-10 2004-09-16 Bdd Group Holding Ag Verwendung von α-Liponsäure oder deren physiologisch verträgliche Salze zur Behandlung von LDL-Hypercholesterinämie
DE10159245A1 (de) * 2001-12-03 2003-06-18 Degussa Stabile, saure, wässrige Lösung enthaltend alpha-Liponsäure(-Derivate), Verfahren zu deren Herstellung sowie ihre Verwendung
CN1853626B (zh) * 2005-04-29 2010-10-06 上海医药工业研究院 一种供注射用的硫辛酸冻干制剂
ATE418976T1 (de) 2005-08-04 2009-01-15 Extarma Ag Flüssige zusammensetzung enthaltend arginine und alpha-liponsäure zur verbesserung der sexuellen funktion
IT1399923B1 (it) 2010-05-11 2013-05-09 Cbb Net S A Procedimento di preparazione di sali dell'acido (r) alfa-lipoico loro formulazione ed uso nelle composizioni farmaceutiche in forma di compresse che li contengono
EP2389931A1 (en) * 2010-05-21 2011-11-30 Raw Materials Internatinal LLC Pharmaceutical aqueous compositions comprising lipoic acid as an antioxidant
ITMI20111452A1 (it) * 2011-07-29 2013-01-30 Istituto Biochimico Naz Sav Io Srl Soluzione basica di acido alfa-lipoico e suoi usi
IT202000009577A1 (it) 2020-04-30 2021-10-30 Fatro Spa Formulazioni iniettabili di acido lipoico per il trattamento dello stress ossidativo e delle alterazioni metaboliche

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1056784B (de) * 1956-05-24 1959-05-06 Istituto Sieroterapico Italian Verfahren zur Herstellung von stabilen Injektionsloesungen der 6,8-Thioctsaeure
DE1047991B (de) * 1957-11-20 1958-12-31 Nordmark Werke Gmbh Verfahren zur Herstellung chemisch stabiler, untoxischer, steriler Injektionsloesungen von Thioctsaeure
DE1095991B (de) * 1959-05-09 1960-12-29 Chemiewerk Homburg Zweignieder Verfahren zur Herstellung einer stabilen und injizierbaren 1,2-Dithia-cyclopentan-3-valeriansaeure enthaltenden Loesung
FR4630M (enExample) * 1965-06-09 1966-11-28
ES323195A1 (es) * 1966-02-17 1966-12-01 Ferrer Labor Procedimiento de obtenciën de compuestos de acciën antiacidëtica
DE1617740B1 (de) * 1967-09-25 1971-11-04 Pfrimmer & Co J Verfahren zum Stabilisieren von Alfa-Liponsäure
ZA716628B (en) * 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
DE2629845A1 (de) * 1976-07-02 1978-01-05 Geb Graze Erika Graze Infusions- bzw. injektionsloesungen bzw. waessrige konzentrate zu deren bereitung zur therapeutischen restituion des zellulaeren energiestoffwechsels und der koerpereigenen regelfunktion
GB1504767A (en) * 1976-08-23 1978-03-22 Beecham Group Ltd Antibiotic compositions
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten

Also Published As

Publication number Publication date
GR3003517T3 (enExample) 1993-03-16
PT89144A (pt) 1989-12-29
PT89144B (pt) 1993-05-31
ES2038733T3 (es) 1993-08-01
IE60877B1 (en) 1994-08-24
EP0318891B1 (de) 1992-01-02
ATE70974T1 (de) 1992-01-15
EP0318891A1 (de) 1989-06-07
IE883618L (en) 1989-06-04

Similar Documents

Publication Publication Date Title
DE3867445D1 (de) Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
MY100559A (en) Improvements in or relating to phenethanolamines.
BR8806457A (pt) Composicao de sulfeto de polifenileno e metodo para produzir uma composicao de sulfeto de polifenileno
ES8506450A1 (es) Procedimiento para higienizar o pasterizar fribrinogeno humano
ES8603271A1 (es) Un metodo de producir una composicion de interleuquina-2
HU896498D0 (en) Process for preparation of low volatility salts
FI845004A0 (fi) Munskoeljningsloesning.
BG44537A3 (en) Method for preparing of 2- amino- 3- ethoxycarbonylamino- 6- (p- fluor- benzylamino)- piridine gluconate
PT86233A (fr) Procede de preparation d:une variant de l:hirudine
DE3571989D1 (en) Salts of 5'-methylthio-5'-deoxyadenosine with long-alkyl chain sulphonic acids
ATE103166T1 (de) Haarbehandlungszusammensetzung.
DK443988A (da) Injektionspraeparat indeholdende modificeret tpa
DE3687171D1 (de) Kristallines triethylaminsalz von cefbuperazon.
FI903692A7 (fi) N5, N10-metyleeni-5,6,7,8-tetrahydrofoolihapon suolat
DE3660591D1 (en) New carnitine salts particularly suitable for oral use
NZ219284A (en) Fluoboric acid salt of n-tridecyl-2,6-dimethylmorpholine and pesticidal compositions
BG50651A1 (en) Method for the preparation of ammonium salt of hydroquinonemonosulphonic acid
JPS5533446A (en) Amino acid transfusion for postoperative patient
ATE31623T1 (de) Injizierbare zusammensetzungen von bbm-928a.
EP0327259A3 (en) Agent for animal growth promotion, its preparation and use
ATE99675T1 (de) Verfahren zur herstellung von salzen der mercaptoaethylsulfonsaeure.
FI884293A0 (fi) Foerfarande foer foerhindrande av tillvaext av mikroorganismer i vattenhaltig vaetska.

Legal Events

Date Code Title Description
8380 Miscellaneous part iii

Free format text: DER PATENTINHABER LAUTET RICHTIG: ASTA MEDICA AG, 6000 FRANKFURT, DE

8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: ASTA MEDICA AG, O-8020 DRESDEN, DE

8365 Fully valid after opposition proceedings
8327 Change in the person/name/address of the patent owner

Owner name: VIATRIS GMBH & CO. KG, 60314 FRANKFURT, DE

8327 Change in the person/name/address of the patent owner

Owner name: VIATRIS GMBH & CO. KG, 61352 BAD HOMBURG, DE

8327 Change in the person/name/address of the patent owner

Owner name: MEDA PHARMA GMBH & CO. KG, 61352 BAD HOMBURG, DE